Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2008
03/20/2008WO2008032678A1 Adhesive preparation
03/20/2008WO2008032665A1 Novel phenylacetic acid derivative
03/20/2008WO2008032432A1 Gel type enteric nutrient
03/20/2008WO2008032222A2 Treatment of vertigo with acetyl-l-leucine
03/20/2008WO2008032212A2 Colored or colorable foamable composition and foam
03/20/2008WO2008032204A1 Substituted pyridylmethyl bicyclocarboxyamide compounds
03/20/2008WO2008032191A2 Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
03/20/2008WO2008032171A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10
03/20/2008WO2008032162A1 Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors
03/20/2008WO2008032156A1 Diaryl ether derivatives and uses thereof
03/20/2008WO2008032153A2 Calreticulin for its use as a medication for the treatment of cancer in a mammal
03/20/2008WO2008032140A1 Antibiotic chemical structure obtained from the strain streptomyces sp. bs46 and its use against methicillin-resistant bacteria
03/20/2008WO2008032107A1 Solid dosage form of olmesartan medoxomil and amlodipine
03/20/2008WO2008032104A1 One pot synthesis of taxane derivatives and their conversion to paclitaxel and docetaxel
03/20/2008WO2008032103A2 Process for the preparation of an (rp)-8-substituted camps
03/20/2008WO2008032099A2 Process for the preparation of montelukast, and intermediates therefor
03/20/2008WO2008032091A1 4-benzimidaz0lyl-6-m0rph0lin0-2-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
03/20/2008WO2008032089A1 4-benzimidaz0lyl-2-m0rph0lin0-6-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
03/20/2008WO2008032086A1 2-benzimidazolyl-6-morpholino-4-phenylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
03/20/2008WO2008032077A1 Pyrimidine derivatives
03/20/2008WO2008032072A1 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
03/20/2008WO2008032064A1 Pyrimidine derivatives
03/20/2008WO2008032060A1 4-benzimidaz0lyl-6-m0rph0lin0-2-piperazinylpyrimidine derivatives as p13k and mtor inhibitors for the treatment of proliferative disorders
03/20/2008WO2008032041A1 Pyrimidine derivatives having inhibitory activity against pi3k enzymes
03/20/2008WO2008032036A1 6-benzimidaz0lyl-2-m0rph0lin0-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
03/20/2008WO2008032033A1 4-benzimidazolyl-2-morpholino-6-piperazinylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
03/20/2008WO2008032028A1 2 -benzimidazolyl- 6 -morpholino-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
03/20/2008WO2008032027A1 Pyrimidine derivatives
03/20/2008WO2008031928A1 Use of milnacipran for reducing the rewarding properties of alcohol during or after an alcohol withdrawal treatment
03/20/2008WO2008031888A2 Condensed pyrimidinones active on glutamatergic receptors
03/20/2008WO2008031886A1 Process for preparing granules of hydrophilic vitamins
03/20/2008WO2008031875A1 Adenosine derivatives as a2a receptor agonists
03/20/2008WO2008031842A1 Inhibitors of gpr87 for cancer therapy
03/20/2008WO2008031835A2 Method of treating autoimmune diseases using vegf-pathway inhibitors
03/20/2008WO2008031831A2 Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
03/20/2008WO2008031820A2 Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors
03/20/2008WO2008031817A2 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors
03/20/2008WO2008031811A1 Nitrate esters of aminoalcohols
03/20/2008WO2008031799A1 Use of piperazine compounds for the treatment of neurodegenerative diseases
03/20/2008WO2008031788A1 Aminoazepine derivatives as highly efficient inhibitors of the inducible nitric oxide synthase
03/20/2008WO2008031782A1 Pharmaceutical composition comprising a plurality of mini-tablets comprising a factor xa inhibitor
03/20/2008WO2008031772A1 Azabicyclic compounds as inhibitors of monoamines reuptake
03/20/2008WO2008031771A2 3-azabicyclo [4. 1. 0] heptane derivatives for the treatment of depression
03/20/2008WO2008031735A1 Pyridine- and quinoline-pyrimidine-derivatives
03/20/2008WO2008031734A1 5-phenyl-nicotinamide derivatives
03/20/2008WO2008031623A1 Pharmaceutical formulations comprising clopidogrel
03/20/2008WO2008031602A1 Food supplementation composition containing one or more vitamin d3 compounds and one or more magnesium salts
03/20/2008WO2008031594A1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors
03/20/2008WO2008031572A1 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of cartilage degradation or cartilage damage in joints
03/20/2008WO2008031569A1 Means for increasing intracellular levels of protoporphyrin ix and use thereof
03/20/2008WO2008031556A2 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions
03/20/2008WO2008031513A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivates as stimulators of guanylate cyclase for cardiovascular disorders
03/20/2008WO2008031509A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS
03/20/2008WO2008031508A1 TARTRATE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS
03/20/2008WO2008031501A2 2-phenoxy nicotine acid derivative and use thereof
03/20/2008WO2008031500A1 4-phenoxy-nicotine acid derivatives and use thereof as ppar-modulators
03/20/2008WO2008031465A1 Nano-vehicle for the transcutaneous transport, preparation containing the same and its use
03/20/2008WO2008031440A2 Isoniazid mediated healing of wounds and ulcers
03/20/2008WO2008031437A2 Treatment of asthma, eczema and/or allergy using antibiotics
03/20/2008WO2008031358A1 1,2-dihydroxy-3-methyl-9,10-anthraquinone in the manufacture of medicaments for treating cancers
03/20/2008WO2008031357A1 (3z)-3-(1h-pyrrol-2-ylmethylene)-1,3-dihydro-2h-indol-2-one in manufacture of medicaments for treating cancers
03/20/2008WO2008031332A1 Use of fucoidan in preparation of medicaments for the treatment of cardiovascular and cerebrovascular diseases
03/20/2008WO2008031286A1 Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof
03/20/2008WO2008031285A1 Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process
03/20/2008WO2008031264A1 Furost-5-ene-3, 22, 26-triol glycoside compound for preventing and treating cancer
03/20/2008WO2008031227A1 Diaryl piperidine compounds as calcium channel blockers
03/20/2008WO2008031221A1 Isovaline for treatment of pain
03/20/2008WO2008031212A1 Creatine pyroglutamic acid salts and methods for their production and use in individuals
03/20/2008WO2008031188A1 Vitamin d compositions and method of administration to a human being
03/20/2008WO2008031184A1 Creatine pyroglutamic acid salts and methods for their production and use in individuals
03/20/2008WO2008031182A1 Process for synthesis and incorporation of nitric oxide donors in macromolecular compositions
03/20/2008WO2008031171A1 Pro-oxidant anti-cancer compounds
03/20/2008WO2008019276A3 Solid forms of (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of their use
03/20/2008WO2008019090A3 Agonists of the sphingosine-1-phosphate receptor
03/20/2008WO2008017466A8 Pharmaceutically active tetrahydroisoquinoline-substituted benzimidazole derivatives
03/20/2008WO2008017000A3 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy
03/20/2008WO2008016702A3 Combined use of (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1(2-thiazolyl)-1,8-naphthyridine-3-carboxylic
03/20/2008WO2008016700A3 N-oxide compounds for therapeutics uses
03/20/2008WO2008016692A3 Chemical compounds
03/20/2008WO2008016677A3 Preparation and utility of deuterated amphetamines
03/20/2008WO2008016661A3 Morpholino compounds for treating inflammatory and demyelinating diseases and cancers
03/20/2008WO2008015403A9 Induction of analgesia in neuropathic pain
03/20/2008WO2008015190A3 Treatment and prevention of excessive scarring
03/20/2008WO2008015137A3 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
03/20/2008WO2008014247A3 4 -arylalkoxymethyl-4- phenyl piperidines and their use as neurokinin receptor antagonists for the treatment of cns disorders
03/20/2008WO2008014108A3 Antimicrobial oxazolidinone prodrugs
03/20/2008WO2008013773A3 Quinine products, method of manufacture, and method of use
03/20/2008WO2008012583A3 Cyclohexenone and cyclohexanone derivatives
03/20/2008WO2008012470A3 Substituted imidazolone derivatives, preparation and uses
03/20/2008WO2008011478A3 Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
03/20/2008WO2008009866A3 Combination of modafinil and an antagonist or inverse agonist of the h3 receptor
03/20/2008WO2008009750A3 Macrocyclic compounds useful as bace inhibitors
03/20/2008WO2008008907A3 Antiviral agents
03/20/2008WO2008008857A3 Thiolated macromolecules and methods of making and using thereof
03/20/2008WO2008008786A3 Pre- and intra- operative imaging of bladder cancer
03/20/2008WO2008008608A3 Method of treating and preventing secondary hyperparathyroidism
03/20/2008WO2008006819A3 Use of ppar-alpha agonists to treat skeletal muscle wasting disorders
03/20/2008WO2008005910A3 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
03/20/2008WO2008005572A3 Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof
03/20/2008WO2008005345A3 Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions
1 ... 3330 3331 3332 3333 3334 3335 3336 3337 3338 3339 3340 3341 3342 3343 3344 3345 3346 3347 3348 3349 3350 ... 7860